Hyung, J., Kim, B., Yoo, C., Kim, K., Jeong, J. H., Chang, H., & Ryoo, B. (2019). Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin. Cancer Res Treat.
Style de citation ChicagoHyung, Jaewon, Bumjun Kim, Changhoon Yoo, Kyo-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, et Baek-Yeol Ryoo. "Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression After First-Line Gemcitabine Plus Cisplatin." Cancer Res Treat 2019.
Style de citation MLAHyung, Jaewon, et al. "Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression After First-Line Gemcitabine Plus Cisplatin." Cancer Res Treat 2019.